Xi ElevenLex FIFA & CAS LEGAL AI Research this case with LexXi
Menu

CAS Case Digest · Verified against the full award text

CAS 2025/A/11312 — World Anti-Doping Agency (WADA) v. CELAD & Patrick Chinedu Ike Origa

"Origa" · CAS overturned a Spanish TAD ruling that had annulled a four-year ban for nandrolone on a missing-signature formality.

Award date10 August 2026
PanelSole Arbitrator: Mr Alex McLin, Attorney-at-law in Lausanne, Switzerland
OutcomeWADA's appeal upheld in its entirety; TAD decision of 31 January 2025 set aside; Patrick Chinedu Ike Origa found to have committed ADRVs under Articles 22.1(a) and 22.1(b) of the Spanish Royal Decree and sanctioned with a four-year period of ineligibility starting from the date of the Award, with credit for any provisional suspension or ineligibility effectively served.
ProvisionsArt. 22.1(a) Spanish ADA 2013 (Organic Law 3/2013) Art. 22.1(b) Spanish ADA 2013 Art. 23.1 Spanish Royal Decree (Real Decreto-ley 3/2017) Art. 39.6(e) Spanish Royal Decree Art. 40.6 Spanish Royal Decree Art. 3.2.3 2015 WADC Art. 10.2.3 2015 WADC Art. 13.1.3 WADC Art. 13.2.3.2 WADC Art. 13.2.3.5 WADC Art. 47.1(a) Spanish Law 39/2015 Art. R47 CAS Code Art. R48 CAS Code Art. R49 CAS Code Art. R54 CAS Code Art. R55 CAS Code Art. R57 CAS Code Art. R58 CAS Code Art. R44.5 CAS Code Art. 178 PILA Art. 182(3) PILA Art. 186(1bis) PILA Art. 190(2)(d) PILA Art. V(1)(b) New York Convention Art. 49.5 Spanish ADA 2021 Art. 1.2 Spanish ADA 2021 Arts. 30.1 and 30.3 Spanish Royal Decree

What happened in Origa

Patrick Chinedu Ike Origa, a professional Spanish sprinter, tested positive for 19-norandrosterone (a metabolite of nandrolone, a non-Specified Substance) at the Campeonato Absoluto de Atletismo de Cataluña in Barcelona on 14 July 2019. CELAD, the Spanish national anti-doping organisation, sanctioned him on 25 October 2024 with a four-year suspension of his federation licence, a four-year ban from sporting office, and disqualification of his results. The Athlete appealed to the Spanish Administrative Court for Sport (TAD), which on 31 January 2025 annulled the CELAD decision solely because the Doping Control Officer's signature was absent from the electronic chain of custody form, treating this as a violation of the presumption of innocence under Article 47.1(a) of Spanish Law 39/2015. WADA appealed to CAS. The Sole Arbitrator set aside the TAD decision, finding: (1) the alleged procedural departure did not actually occur because WADA produced the signed chain of custody form from the sample collection authority; and (2) even if the signature had been missing, the TAD was required under Article 39.6(e) of the Spanish Royal Decree and Article 3.2.3 of the 2015 WADC to assess whether the departure could reasonably have caused the ADRV — an analysis the TAD entirely omitted. The Athlete offered no explanation for the presence of nandrolone, so the four-year default sanction applied. The case matters because it reinforces that procedural formalities cannot override the causation requirement in anti-doping proceedings.

Procedural history of CAS 2025/A/11312

On 14 July 2019, the Athlete provided a doping control sample at a Catalan athletics championship in Barcelona. Analysis revealed 19-norandrosterone. On 25 October 2024, CELAD issued a decision finding a violation of Article 22.1(a) of the Spanish ADA 2013 and imposing a four-year suspension of the federation licence, a four-year ban from sporting office, and disqualification of results. On 29 October 2024, the Athlete appealed to the TAD. On 31 January 2025, the TAD upheld the appeal and annulled the CELAD decision, finding the absence of the DCO's signature on the electronic chain of custody form violated the presumption of innocence under Article 47.1(a) of Law 39/2015. On 27 March 2025, WADA filed a Statement of Appeal with CAS under Articles R47 and R48 of the CAS Code, seeking to set aside the TAD decision and reinstate a four-year period of ineligibility. CELAD filed an Answer on 16 July 2025; the Athlete never responded. The Sole Arbitrator decided on the papers.

Key holdings in CAS 2025/A/11312

How the CAS panel reasoned

The Sole Arbitrator first resolved three preliminary issues. On CELAD's standing, he followed CAS 2019/A/6226 and CAS 2024/A/10584 & 10585, holding that the TAD exercises only review powers and lacks disciplinary authority of its own, so CELAD as the NADO is the proper respondent. On lis pendens, he applied Article 186(1bis) PILA and Article R55 of the CAS Code, finding that the mere possibility of contradictory state-court decisions is not a serious reason to suspend proceedings, and CELAD had not shown its rights would be harmed. On the Athlete's absence, he applied the CAS notification standard — that a communication is deemed received once it enters the recipient's sphere of influence — and was satisfied that diligent efforts by courier and email, confirmed by tracking evidence of active email use as late as 9 July 2025, satisfied due process. On the merits, the Arbitrator found the TAD's reasoning doubly flawed: first, the signed chain of custody form produced by WADA demonstrated no procedural departure had actually occurred; second, even hypothetically, both Article 39.6(e) of the Spanish Royal Decree and Article 3.2.3 of the 2015 WADC required the TAD to assess causation before invalidating the ADRV — an analysis the TAD entirely omitted by treating the missing signature as automatically dispositive. The Arbitrator rejected the TAD's reliance on Article 47.1(a) of Law 39/2015 as failing to engage with the hierarchy of applicable anti-doping norms.

Why Origa matters in CAS jurisprudence

Origa reinforces the hierarchy of anti-doping norms over general administrative law in Spanish proceedings: a national review tribunal cannot annul a doping sanction on a procedural formality without first applying the causation test mandated by Article 3.2.3 WADC and Article 39.6(e) of the Spanish Royal Decree. The award also consolidates CAS jurisprudence on CELAD's standing as respondent in appeals against TAD decisions, following CAS 2019/A/6226 and CAS 2024/A/10584 & 10585, and provides practical guidance on satisfying due-process notification obligations toward non-participating athletes.

Decision: WADA's appeal upheld in its entirety; TAD decision of 31 January 2025 set aside; Patrick Chinedu Ike Origa found to have committed ADRVs under Articles 22.1(a) and 22.1(b) of the Spanish Royal Decree and sanctioned with a four-year period of ineligibility starting from the date of the Award, with credit for any provisional suspension or ineligibility effectively served.

Cases cited in this award

CAS 2018/A/5888 CAS 2022/A/8737 CAS 2019/A/6226 CAS 2024/A/10584 & 10585 CAS 2009/A/1881 CAS 2021/O/7977

Frequently asked questions about Origa

Why did CAS overturn the Spanish TAD decision in the Origa case?

The TAD had annulled CELAD's four-year ban solely because the Doping Control Officer's signature was absent from the electronic chain of custody form, treating this as a violation of the presumption of innocence under Article 47.1(a) of Spanish Law 39/2015. CAS found this reasoning doubly flawed: WADA produced the signed form from the sample collection authority, showing no departure had actually occurred; and even if it had, both Article 39.6(e) of the Spanish Royal Decree and Article 3.2.3 of the 2015 WADC required the TAD to assess whether the departure could reasonably have caused the ADRV — an analysis the TAD entirely omitted.

What sanction did Patrick Chinedu Ike Origa receive and why was it four years?

Origa received a four-year period of ineligibility, including suspension of his federation licence, starting from the date of the CAS Award on 10 August 2026. Nandrolone (detected as 19-norandrosterone) is a non-Specified Substance under the WADC Prohibited List, so the default sanction under Article 23.1 of the Spanish Royal Decree is four years unless the athlete proves lack of intent. Origa provided no explanation for the presence of the substance and offered no evidence to rebut presumed intent, so the four-year default applied.

Does CELAD have standing to be a respondent in a CAS appeal against a TAD decision in the Origa case?

Yes. Following CAS 2019/A/6226 and CAS 2024/A/10584 & 10585, the Sole Arbitrator confirmed that CELAD has standing to be sued even though the TAD — not CELAD — issued the appealed decision. The TAD exercises only review powers and has no disciplinary authority of its own; the subject-matter of the appeal is whether the Athlete committed an ADRV, which is the object of CELAD's sanctioning power as the Spanish NADO. The TAD, as an independent adjudicatory body, is not a WADC signatory and therefore cannot be named as a party.

Was the Origa CAS arbitration validly conducted even though the athlete never responded?

Yes. The Sole Arbitrator examined the notification issue ex officio under Article 182(3) PILA, Article 190(2)(d) PILA, and Article V(1)(b) of the New York Convention. The CAS Court Office made numerous courier and email attempts; one courier delivery was ultimately successful, emails were accepted by the Athlete's mail server without bounce-backs, and tracking evidence confirmed one email address was actively consulted as late as 9 July 2025. The Arbitrator was satisfied that the Athlete had the opportunity to obtain knowledge of the proceedings and that his right to be heard had been respected despite his failure to engage.

Go deeper than the digest

Ask LexXi how this award has been applied since, compare it with related jurisprudence across 14,200+ indexed FIFA & CAS documents, and get answers with verified citations.

Ask LexXi about Origa — free

Topics: Doping, ethics & governance at CAS

Source: official award. This digest was generated by LexXi from the full award text and machine-verified against it — every figure, article and citation above appears in the source. It is an editorial summary, not legal advice. See how ElevenLex verification works.